Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

New compounds show promise as nonsteroidal treatments for hair loss.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Biological therapy boosts the immune system to effectively fight melanoma.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Sorafenib can cause a unique skin reaction.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Minoxidil helps hair growth by improving blood vessel function.

Some dibenzo compounds might help treat cancer with fewer side effects.

Including androgens in hormone therapy may lower breast cancer risk.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.